Skip to main content
. Author manuscript; available in PMC: 2017 May 17.
Published in final edited form as: Immunity. 2016 May 3;44(5):1204–1214. doi: 10.1016/j.immuni.2016.04.008

Figure 5. HBeAg is essential for HBV persistence in TGD mice.

Figure 5

(A) 12 control mice and 11 TGD mice were injected with the HBeAg-negative HBV DNA (i.e., MT HBV DNA). (B) 12 control mice and 7 HBeAg-naïve TGD mice were injected with the wild-type HBV genomic DNA (i.e., WT HBV DNA). The sera were collected at the time points indicated and analyzed for HBsAg (upper panels) and HBV DNA (lower panels). The results represent the mean. See also Figure S3.